Option chain shows key data for Biote's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Biote.

Biote (NASDAQ:BTMD) Stock, Option Chain

Biote

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Long Ideas

News

Penny Stocks

Small Cap

Insider Trades

Markets

Trading Ideas

BTMD

CRYM

ERAS

HOWL

The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Over $4 Million Bet On Werewolf Therapeutics? Check Out These 4 Penny Stocks Insiders Are Buying

Pre-Market Outlook

Movers

AMPE

ATXG

AVCT

BIAF

CEMI

CLBS

GFAI

GSUN

Hollsys Automation Technologies INTERNATIONAL

HOLI

ISPO

KPTI

LULU

NBEV

NINE

PIXY

PXMD

SGML

SHIP

SHPH

TAOP

VRAX

RVPH

Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket

AIHS

BGXX

CFRX

CMRA

FIVE

GRNQ

HIVE

HPCO

MEGL

NTNX

NUWE

NVDA

OBSV

OKTA

PSTG

SMTC

SONN

STIX

THMO

TIVC

VEEV

VXRT

ZFOX

Gainers


	Bright Green Corporation (NASDAQ: BGXX) shares rose 63.8% to $2.26 in pre-market trading after gaining around 33% on Wednesday.


Why Nutanix Is Trading Higher By 16%; Here Are 33 Stocks Moving Premarket

Biote Corp

Press Releases

Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares

Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

Biote Reports Second Quarter 2024 Financial Results

Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

Biote Reports Third Quarter 2024 Financial Results

AccessHope Expands Executive Leadership Team Amid Rapid Growth and Upcoming Market Expansion

Biote Announces CEO Retirement and Succession Plan

Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call

Biote Reports Fourth Quarter and Full Year 2024 Financial Results

Biote Announces Purchase of Shares by Directors and CEO

HOLX

MYGN

PODD

REXR

Aardvark Therapeutics, Inc. - Common Stock

Aardvark Therapeutics

Aclaris Therapeutics, Inc. - Common Stock

Aclaris Therapeutics

ALT5 Sigma

Assertio Holdings

Bioage Labs

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Context Therapeutics

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Contineum Therapeutics, Inc. - Common stock

Contineum Therapeutics

Journey Medical Corporation - Common Stock

Journey Medical

Fulcrum Therapeutics, Inc. - Common Stock

Fulcrum Therapeutics

MBX Biosciences

Nektar Therapeutics

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics

Nutriband

OptiNose

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals

Pliant Therapeutics

Cassava Sciences

scPharmaceuticals

Telomir Pharmaceuticals, Inc. - Common Stock

Telomir Pharmaceuticals

Terns Pharmaceuticals, Inc. - Common Stock

Terns Pharma

Third Harmonic Bio

Veru

Ventyx Biosciences

Craig-Hallum

Roth MKM

B. Riley Securities

Jefferies

Truist Securities

Comments

Biote

Biote (BTMD) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga